Literature DB >> 8761011

Endocrine, paracrine and autocrine actions of prolactin on immune cells.

L Matera1.   

Abstract

The immune response is regulated by locally released factors, collectively referred to as cytokines. Data on the human immune system have convincingly demonstrated that the hormone prolactin (PRL), in addition to exerting its endocrine control on the immune system, acts as a cytokine in that it is released within the immune system and regulates the lymphocyte response by paracrine and autocrine mechanisms. Both lymphocyte and pituitary PRLs are under the control of immune factors. Synthesis of human PRL by lymphocytes is induced by T-cell stimuli, while increased release of PRL by the pituitary, observed in vivo after immune challenge, may be mediated by cytokines produced by monocyte-macrophages. Since hyperprolactinemia and hypoprolactinemia are both immunosuppressive, physiological levels of circulating PRL must be necessary to maintain basal immunocompetence. The effects of Cyclosporin (CsA) on IL-2 and PRL gene activation and the analysis of the intracellular signaling events downstream IL-2 and PRL receptors suggest coordinate actions of these two cytokines during T cell activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761011     DOI: 10.1016/0024-3205(96)00225-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  20 in total

1.  Immune function in healthy inner-city children.

Authors:  J A Bartlett; A R Goldklang; S J Schleifer; S E Keller
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

Review 2.  Extrapituitary production of anterior pituitary hormones: an overview.

Authors:  S Harvey; C Arámburo; E J Sanders
Journal:  Endocrine       Date:  2011-11-15       Impact factor: 3.633

3.  Sex-dependent roles of prolactin and prolactin receptor in postoperative pain and hyperalgesia in mice.

Authors:  M J Patil; D P Green; M A Henry; A N Akopian
Journal:  Neuroscience       Date:  2013-08-29       Impact factor: 3.590

4.  Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues.

Authors:  Heather R Christensen; Michael K Murawsky; Nelson D Horseman; Tara A Willson; Karen A Gregerson
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

5.  Prolactin regulates TRPV1, TRPA1, and TRPM8 in sensory neurons in a sex-dependent manner: Contribution of prolactin receptor to inflammatory pain.

Authors:  Mayur J Patil; Shivani B Ruparel; Michael A Henry; Armen N Akopian
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-10       Impact factor: 4.310

6.  Extrapituitary prolactin promoter polymorphism in Czech patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Markéta Fojtíková; Marie Cerná; Pavlína Cejková; Sárka Ruzicková; Ctibor Dostál
Journal:  Ann Rheum Dis       Date:  2007-05       Impact factor: 19.103

7.  Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.

Authors:  L Matera; G Bellone; J J Lebren; P A Kelly; E L Hooghe Peters; P F Di Celle; R Foa; M Contarini; G Avanzi; V Asnaghi
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 8.  Minireview: prolactin regulation of adult stem cells.

Authors:  Lucila Sackmann-Sala; Jacques-Emmanuel Guidotti; Vincent Goffin
Journal:  Mol Endocrinol       Date:  2015-03-20

9.  Bromocriptine restores tolerance in estrogen-treated mice.

Authors:  E Peeva; C Grimaldi; L Spatz; B Diamond
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

10.  Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.

Authors:  T Bauernhofer; I Kuss; U Friebe-Hoffmann; A S Baum; G Dworacki; B K Vonderhaar; T L Whiteside
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.